BOLTON SECURITIES CORPORATION’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.9K Hold
7,000
– – ﹤0.01% 1541
2026
Q2
$39.8K Hold
7,000
– – ﹤0.01% 1416
2026
Q1
$64K Buy
+7,000
New +$98.3K ﹤0.01% 1165

Other funds holding LENZ

BOLTON SECURITIES CORPORATION's LENZ Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION held its LENZ Therapeutics (LENZ) position steady in Q3 2026 at 7,000 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

BOLTON SECURITIES CORPORATION first reported a position in LENZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $64K in Q1 2026. 91 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 7,000 shares of LENZ Therapeutics worth $26.9K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION left its LENZ Therapeutics share count unchanged in Q3 2026.
  • LENZ Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1541 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's LENZ Therapeutics position peaked at $64K in Q1 2026.
  • 91 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.